Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens

OBJECTIVE: To investigate, in detail, the effects of rituximab (RTX), an off-label drug for treating multiple sclerosis (MS) disease on preventing and/or ameliorating experimental autoimmune encephalomyelitis (EAE). METHODS: Using bioinformatics analysis of publicly available transcriptomics data, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-ani, Mena R, Raju, Tom K, Hachim, Mahmood Y, Hachim, Ibrahim Y, Elemam, Noha M, Guimei, Maha, Bendardaf, Riyad, Maghazachi, Azzam A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082624/
https://www.ncbi.nlm.nih.gov/pubmed/32214838
http://dx.doi.org/10.2147/JIR.S243514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082624/
https://www.ncbi.nlm.nih.gov/pubmed/32214838
http://dx.doi.org/10.2147/JIR.S243514

Ejemplares similares